Viatris’ investigational blepharitis ointment failed to achieve the primary endpoint in its Phase III trial, prompting the ...

President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

Duquesne Family Office's billionaire chief dumped his fund's stake in Wall Street's artificial intelligence (AI) darling in ...

We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

According to Benzinga Pro, Teva Pharmaceutical Indus's peer group average for short interest as a percentage of float is 3.59 ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts.

Teva is proud to be included in the 2025 TIME and Statista list of the World’s Most Sustainable Companies, a recognition that underscores our commitment to building a healthier, more sustainable world ...

That being said, we’re here with a list of the 16 most promising stocks according to Wall Street analysts.